The company has been awarded multiple patents for its innovative and unique medical process called The AVACEN Treatment Method (ATM), which is expected to allow multiple therapeutic uses to alleviate symptoms associated with a circulatory, neurological, lymphatic, or endocrinal dysfunction, or any combination thereof. The AVACEN 100 is cleared by the FDA as a heat therapy system indicated for the temporary relief of minor muscle and joint pain and stiffness, joint pain associated with arthritis, muscle spasms, minor strains and sprains, muscular relaxation, and the temporary increase of local circulation where applied. The device has also received CE Mark approval to treat widespread pain associated with fibromyalgia in the European Union's 28 member countries.